Medpace Holdings, Inc.
MEDP· Nasdaq
Released Feb 13, 2023, after the close
10-K filed Feb 14, 2023, 45 days after period end · 0001668397-23-000008
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $394.10M | $308.55M | $259.68M | $229.89M |
| Net Income | $68.67M | $50.03M |
Medpace Holdings, Inc. · CIK 1668397 · Engraved from SEC EDGAR
| $50.87M |
| $29.81M |
| EPS Diluted | — | — | — | $0.78 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.